Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
A phase 2 trial (SYNERGY-NASH) first demonstrated in vivo that GLP-1RA can achieve histological reversal of hepatic fibrosis in MASLD
Our team can check your benefits and explain potential out-of-pocket costs before your visit
Bacterial DNA was isolated from the feces using a QIAamp PowerFecal DNA Kit (12830-50, QIAGEN), and PCR was carried out with 50 g DNA template to quantify 16S DNA gene expression using bacterial primers (8F and 338R) and V6
Updates should not imply a causal association, but reflect a class level awareness, the TGA said
For air travel, carry your GLP-1 medication in your hand luggage rather than checked baggage